HG-73 SAFETY AND FEASIBILITY OF A MULTI-INSTITUTIONAL PHASE II TRIAL INCOPORATING BIOPSY AND MOLECULARLY DETERMINED TREATMENT OF CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED DIFF...

Por Wright, Karen D., Bandopadhayay, Pratiti, Gourmnerova, Liliana, Chi, Susan N., Manley, Peter, Marcus, Karen, Kannan, Geoffrey, Banerjee, Anu, Becher, Oren, Bendel, Anne, Bowers, Daniel, Bredlau, Amy-Lee, Cohen, Kenneth, Comito, Melani, Elster, Jennifer D., Etzl, Michael, Fisher, Paul G., Gardner, Sharon, Goldman, Stewart, Gururangan, Sridharan, Handler, Michael H., Jabado, Nada, Karajannis, Matthias, Khatib, Ziad, Leary, Sarah E., MacDonald, Tobey J., Monje, Michelle, Nazemi, Kellie, Robison, Nathan J., Rubin, Joshua, Sandler, Eric S., Snuderl, Matija, Wang, Zhihong Joanne, Sinai, Claire E., Greenspan, Lianne, Lawler, Kristen, Neuberg, Donna, Filbin, Mariella, Segal, Rosalind, Suva, Mario L., Beroukhim, Rameen, Ligon, Keith, Gupta, Nalin, Prados, Michael, Kieran, Mark W.
Publicado no Neuro Oncol (2016)